摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-1-chloro-4-morpholino-2-butene | 4633-96-9

中文名称
——
中文别名
——
英文名称
(E)-1-chloro-4-morpholino-2-butene
英文别名
4-(4-chloro-but-2-enyl)-morpholine;1-Morpholino-4-chlor-trans-buten;4-[(E)-4-chlorobut-2-enyl]morpholine
(E)-1-chloro-4-morpholino-2-butene化学式
CAS
4633-96-9
化学式
C8H14ClNO
mdl
——
分子量
175.658
InChiKey
RBMOHURSRGLBOW-OWOJBTEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    86-87 °C(Press: 0.7 Torr)
  • 密度:
    1.070±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    6-甲基-2-苯基嘧啶-4-酮(E)-1-chloro-4-morpholino-2-butenepotassium carbonate 、 potassium iodide 作用下, 以 乙腈 为溶剂, 生成 (E)-4-(4-((6-methyl-2-phenylpyrimidin-4-yl)oxy)but-2-en-1-yl)morpholine
    参考文献:
    名称:
    Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain
    摘要:
    The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (sigma R-1) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. The new compounds were evaluated in vitro in sigma-1 and sigma-2 receptor binding assays. The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model. The most promising derivative was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (137), which exhibited a high binding affinity to sigma R-1 receptor (K-i sigma(1) = 1.06 nM) and good sigma-1/2 selectivity (1344-fold). In in vivo tests, compound 137 exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain. In addition, no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted. These data suggest compound 137 may constitute a novel class of drugs for the treatment of neuropathic pain.
    DOI:
    10.1021/jm501207r
  • 作为产物:
    描述:
    吗啉反式-1,4-二氯-2-丁烯四氢呋喃 为溶剂, 反应 5.0h, 以54%的产率得到(E)-1-chloro-4-morpholino-2-butene
    参考文献:
    名称:
    DTBB催化的4-官能化1-氯-2-丁烯的锂化反应
    摘要:
    的反应Ñ,Ñ二取代(ê)-4-氨基-1-氯-2-丁烯1与过量锂和DTBB的亲电子[E的存在催化量+ =卜吨CHO,苯甲醛,在-78°C下于THF中的Me 2 CO,(CH 2)5 CO,(c -C 3 H 5)2 CO,Me 3 SiCl]在水中水解后,得到预期的1,2-混合物和1,4-二取代的化合物(2和3,分别),可通过快速色谱法轻松分离。当将反应应用于相应的(Z)-起始原料或应用于(Z)-或(E)-氧或含硫的氯化2-丁烯时,其收率要低于硝化前体的收率。
    DOI:
    10.1016/0040-4020(96)00798-3
点击查看最新优质反应信息

文献信息

  • Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain
    作者:Yu Lan、Yin Chen、Xudong Cao、Juecheng Zhang、Jie Wang、Xiangqing Xu、Yinli Qiu、Tan Zhang、Xin Liu、Bi-Feng Liu、Guisen Zhang
    DOI:10.1021/jm501207r
    日期:2014.12.26
    The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (sigma R-1) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. The new compounds were evaluated in vitro in sigma-1 and sigma-2 receptor binding assays. The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model. The most promising derivative was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (137), which exhibited a high binding affinity to sigma R-1 receptor (K-i sigma(1) = 1.06 nM) and good sigma-1/2 selectivity (1344-fold). In in vivo tests, compound 137 exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain. In addition, no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted. These data suggest compound 137 may constitute a novel class of drugs for the treatment of neuropathic pain.
  • DTBB-catalysed lithiation of 4-functionalised 1-chloro-2-butenes
    作者:Fernando F Huerta、Cecilia Gómez、Miguel Yus
    DOI:10.1016/0040-4020(96)00798-3
    日期:1996.10
    The reaction of N,N-disubstituted (E)-4-amino-1-chloro-2-butenes 1 with an excess of lithium and a catalytic amount of DTBB in the presence of an electrophile [E+ = ButCHO, PhCHO, Me2CO, (CH2)5CO, (c-C3H5)2CO, Me3SiCl] in THF at −78°C leads, after hydrolysis with water, to the expected mixture of 1,2- and 1,4- disubstituted compounds (2 and 3, respectively), which could be easily separated by flash
    的反应Ñ,Ñ二取代(ê)-4-氨基-1-氯-2-丁烯1与过量锂和DTBB的亲电子[E的存在催化量+ =卜吨CHO,苯甲醛,在-78°C下于THF中的Me 2 CO,(CH 2)5 CO,(c -C 3 H 5)2 CO,Me 3 SiCl]在水中水解后,得到预期的1,2-混合物和1,4-二取代的化合物(2和3,分别),可通过快速色谱法轻松分离。当将反应应用于相应的(Z)-起始原料或应用于(Z)-或(E)-氧或含硫的氯化2-丁烯时,其收率要低于硝化前体的收率。
查看更多

同类化合物

(4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (2-肟基-氰基乙酸乙酯)-N,N-二甲基-吗啉基脲六氟磷酸酯 鲸蜡基乙基吗啉氮鎓乙基硫酸盐 马啉乙磺酸钾 预分散OTOS-80 顺式4-(氮杂环丁烷-3-基)-2,2-二甲基吗啉 顺式-N-亚硝基-2,6-二甲基吗啉 顺式-3,5-二甲基吗啉 顺-2,6-二甲基-4-(4-硝基苯基)吗啉 非屈酯 雷奈佐利二聚体 阿瑞杂质9 阿瑞吡坦磷的二卞酯 阿瑞吡坦杂质 阿瑞吡坦杂质 阿瑞吡坦 阿瑞吡坦 阿瑞匹坦非对映异构体2R3R1R 阿瑞匹坦杂质A异构体 阿瑞匹坦杂质54 阿瑞匹坦-M3代谢物 钾[2 - (吗啉- 4 -基)乙氧基]甲基三氟硼酸 邻苯二甲酸单吗啉 调节安 试剂2-(4-Morpholino)ethyl2-bromoisobutyrate 茂硫磷 苯甲腈,2-(4-吗啉基)-5-[1,4,5,6-四氢-4-(羟甲基)-6-羰基-3-哒嗪基]- 苯甲曲秦 苯甲吗啉酮 苯基2-(2-苯基吗啉-4-基)乙基碳酸酯盐酸盐 苯二甲吗啉一氢酒石酸盐 苯二甲吗啉 苯乙酮 O-(吗啉基羰基甲基)肟 芬美曲秦 芬布酯盐酸盐 芬布酯 脾脏酪氨酸激酶(SYK)抑制剂 脱氯利伐沙班 脱氟雷奈佐利 羟基1-(3-氯苯基)-2-[(1,1-二甲基乙基)氨基]-1-丙酮盐酸盐 福沙匹坦苄酯 福沙匹坦杂质26 福曲他明 碘化N-甲基丙基吗啉 碘化N-甲基,乙基吗啉 硝酸吗啉 盐酸吗啡啉-D8 甲基吗啉-2-羧酸甲酯2,2,2-三氟乙酸盐 甲基N-[3-(乙酰基氨基)-4-[(2-氰基-4,6-二硝基苯基)偶氮]苯基]-N-乙基-&#x3B2-丙氨酸酸酯 甲基4-吗啉二硫代甲酸酯